Otsuka Holdings Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Otsuka Holdings Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Otsuka Holdings Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Otsuka Holdings Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Otsuka Holdings Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390399A1 | Application | Injectable preparation | A61K31/496; A61K47/10; A61K47/32; A61K47/38; A61K9/0019; A61K9/0024; A61K9/06 | December 07, 2023 |
| US20230389852A1 | Application | Methods, devices and systems that use one or more transducers to heat nerves to evoke neural response without denervating nerves, as well as to denervate nerves | A61B18/1492; A61B18/1815; A61B2018/00702; A61B2018/1861; A61B5/388; A61N7/022 | December 07, 2023 |
| US20230394235A1 | Application | Domain-specific document validation | G06F16/35; G06F40/226; G06F40/242; G06F40/284; G06F40/295 | December 07, 2023 |
| US20230390251A1 | Application | Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inhibitor | A61K31/4245; A61K45/06; A61P35/02 | December 07, 2023 |
| EP4284378A1 | Application | Krebsbehandlung bei patienten mit pten-inaktivierender mutation | A61K31/5365; A61P35/00; C07D498/14 | December 06, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer